Physician profile
Danielle Yvette Singleton
NPI 1700060233
$2,465.05
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,050 · 2020: $384 · 2021: $30.89.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $219.48 | 2019-2020 | |
| Genentech USA, INC. | $214.30 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $213.51 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $187.16 | 2019 | |
| Janssen Biotech, INC. | $155.97 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $149.35 | 2019-2020 | |
| Pfizer INC. | $136.55 | 2019 | |
| Merck Sharp & Dohme LLC | $98.41 | 2019-2020 | |
| Lilly USA, LLC | $90.12 | 2019-2020 | |
| Amgen INC. | $78.83 | 2019-2020 | |
| Celgene Corporation | $70.98 | 2019 | |
| Janssen Pharmaceuticals, INC | $58.79 | 2019-2020 | |
| Emd Serono, INC. | $55.71 | 2019 | |
| Daiichi Sankyo INC. | $55.66 | 2020 | |
| Pharmacyclics LLC, An Abbvie Company | $55.33 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Array Biopharma INC | $54.21 | 2019 | |
| Abbvie INC. | $47.32 | 2019 | |
| Tersera Therapeutics LLC | $44.12 | 2019 | |
| Novartis Pharmaceuticals Corporation | $43.36 | 2019 | |
| Genzyme Corporation | $42.97 | 2019 | |
| Eisai INC. | $35.34 | 2019-2020 | |
| Taiho Oncology, INC. | $34.92 | 2019 | |
| Astellas Pharma US INC | $34.85 | 2020 | |
| Incyte Corporation | $31.82 | 2019-2020 | |
| Seagen INC. | $31.46 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $30.34 | 2019 | |
| Exelixis INC. | $24.54 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $24.29 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.90 | 2019 | |
| Dendreon Pharmaceuticals LLC | $22.54 | 2019 | |
| Acceleron Pharma, INC. | $20.33 | 2020 | |
| Epizyme, INC. | $19.25 | 2020 | |
| Clovis Oncology, INC. | $17.69 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $15.25 | 2019 | |
| Agios Pharmaceuticals, INC. | $14.48 | 2019 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Singleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.